Finding infections earlier is only part of the work. At IDWeek 2026, David Weber, MD, MPH, explored how broader surveillance and emerging technologies could help infection preventionists spend more time supporting safer care.
Part 4 of 4: Why better planning for surgical growth, operational performance, and patient safety requires sterile processing expertise early in the decision-making process.
At IDWeek 2026, Rachel Sidebottom discusses research exploring phage-antibiotic combinations, the potential for predictive modeling, and an investigation identifying an ST5 strain of nontoxigenic Corynebacterium diphtheriae circulating in Albuquerque.
Part 1 of 4: How emerging sterile processing leaders are redefining leadership through trust, accountability, psychological safety, and professional development.
This week in infection prevention: Kenya’s Bundibugyo virus response shows why execution, not just planning, determines outcomes, and France reported the first known human Shamonda virus infection. Our roundup also covers brucellosis, blood donor screening, and long-acting HIV antibody findings from IDWeek 2026.
At IDWeek 2026, Samuel Ntow, MBChB, MPH, discussed research findings of reactive infection screening markers in 18.3% of replacement donor records from rural Ghana, highlighting opportunities for further evaluation and linkage to care.